These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9252409)
1. Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain. Gasparri A; Sidoli A; Sanchez LP; Longhi R; Siccardi AG; Marchisio PC; Corti A J Biol Chem; 1997 Aug; 272(33):20835-43. PubMed ID: 9252409 [TBL] [Abstract][Full Text] [Related]
2. Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion. Colombo B; Longhi R; Marinzi C; Magni F; Cattaneo A; Yoo SH; Curnis F; Corti A J Biol Chem; 2002 Nov; 277(48):45911-9. PubMed ID: 12297497 [TBL] [Abstract][Full Text] [Related]
3. Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity. Strub JM; Garcia-Sablone P; Lonning K; Taupenot L; Hubert P; Van Dorsselaer A; Aunis D; Metz-Boutigue MH Eur J Biochem; 1995 Apr; 229(2):356-68. PubMed ID: 7744058 [TBL] [Abstract][Full Text] [Related]
4. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. Mahata SK; O'Connor DT; Mahata M; Yoo SH; Taupenot L; Wu H; Gill BM; Parmer RJ J Clin Invest; 1997 Sep; 100(6):1623-33. PubMed ID: 9294131 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells. Ratti S; Curnis F; Longhi R; Colombo B; Gasparri A; Magni F; Manera E; Metz-Boutigue MH; Corti A J Biol Chem; 2000 Sep; 275(38):29257-63. PubMed ID: 10875933 [TBL] [Abstract][Full Text] [Related]
6. Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity. Mahata SK; Mahata M; Wakade AR; O'Connor DT Mol Endocrinol; 2000 Oct; 14(10):1525-35. PubMed ID: 11043569 [TBL] [Abstract][Full Text] [Related]
7. Determination of residues in chromogranin A-(16-40) required for inhibition of parathyroid hormone secretion. Angeletti RH; Mints L; Aber C; Russell J Endocrinology; 1996 Jul; 137(7):2918-22. PubMed ID: 8770914 [TBL] [Abstract][Full Text] [Related]
8. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. Lugardon K; Raffner R; Goumon Y; Corti A; Delmas A; Bulet P; Aunis D; Metz-Boutigue MH J Biol Chem; 2000 Apr; 275(15):10745-53. PubMed ID: 10753865 [TBL] [Abstract][Full Text] [Related]
10. A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis. Mahata SK; Mahata M; Yoo SH; Taupenot L; Wu H; Aroda VR; Livsey CV; Taulane JP; Goodman M; Parmer RJ; O'Connor DT Adv Pharmacol; 1998; 42():260-4. PubMed ID: 9327894 [No Abstract] [Full Text] [Related]
11. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562 [TBL] [Abstract][Full Text] [Related]
12. Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. Ferrero E; Scabini S; Magni E; Foglieni C; Belloni D; Colombo B; Curnis F; Villa A; Ferrero ME; Corti A FASEB J; 2004 Mar; 18(3):554-6. PubMed ID: 14734634 [TBL] [Abstract][Full Text] [Related]
13. Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion. Drees BM; Rouse J; Johnson J; Hamilton JW Endocrinology; 1991 Dec; 129(6):3381-7. PubMed ID: 1954912 [TBL] [Abstract][Full Text] [Related]
14. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Briolat J; Wu SD; Mahata SK; Gonthier B; Bagnard D; Chasserot-Golaz S; Helle KB; Aunis D; Metz-Boutigue MH Cell Mol Life Sci; 2005 Feb; 62(3):377-85. PubMed ID: 15723172 [TBL] [Abstract][Full Text] [Related]
15. Identification of a functionally important sequence in the cytoplasmic tail of integrin beta 3 by using cell-permeable peptide analogs. Liu XY; Timmons S; Lin YZ; Hawiger J Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11819-24. PubMed ID: 8876221 [TBL] [Abstract][Full Text] [Related]
16. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods. Stridsberg M; Angeletti RH; Helle KB J Endocrinol; 2000 Jun; 165(3):703-14. PubMed ID: 10828855 [TBL] [Abstract][Full Text] [Related]
17. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells. Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588 [TBL] [Abstract][Full Text] [Related]